Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study
Articolo
Data di Pubblicazione:
2017
Citazione:
Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study / Teerlink, John R.; Voors, Adriaan A.; Ponikowski, Piotr; Pang, Peter S.; Greenberg, Barry H.; Filippatos, Gerasimos; Felker, G. Michael; Davison, Beth A.; Cotter, Gad; Gimpelewicz, Claudio; Boer-Martins, Leandro; Wernsing, Margaret; Hua, Tsushung A.; Severin, Thomas; Metra, Marco. - In: EUROPEAN JOURNAL OF HEART FAILURE. - ISSN 1388-9842. - 19:6(2017), pp. 800-809. [10.1002/ejhf.830]
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Acute heart failure; Mortality; Phase 3 trial; Serelaxin; Worsening heart failure; Cardiology and Cardiovascular Medicine
Elenco autori:
Teerlink, John R.; Voors, Adriaan A.; Ponikowski, Piotr; Pang, Peter S.; Greenberg, Barry H.; Filippatos, Gerasimos; Felker, G. Michael; Davison, Beth A.; Cotter, Gad; Gimpelewicz, Claudio; Boer-Martins, Leandro; Wernsing, Margaret; Hua, Tsushung A.; Severin, Thomas; Metra, Marco
Link alla scheda completa:
Pubblicato in: